Front Desk: 469-391-0070
Surfactant Therapy: A Lifesaver for Respiratory Distress Syndrome
Introduction: Key Points on Surfactant Therapy
Surfactants are medications primarily used to treat respiratory distress syndrome (RDS) in premature infants. They assist the lungs by reducing surface tension, making it easier for the lungs to expand. Surfactants are administered directly into the lungs through a breathing tube and are life-saving treatments for newborns with underdeveloped lungs, commonly used in neonatal intensive care units (NICUs).
Medications within the Surfactant Drug Class
Curosurf (Poractant alfa)
Infasurf (Calfactant)
Survanta (Beractant)
The “generic name” refers to the active ingredient in the medication, while the brand name is given by the manufacturer. The generic name is listed in parentheses next to the brand name.
How Surfactant Works in the Lungs: Mechanism of Action
Surfactants mimic the natural pulmonary surfactant produced in the lungs. Pulmonary surfactant reduces surface tension in the alveoli, the tiny air sacs where oxygen exchange occurs. In premature infants, the lungs may not produce enough natural surfactant, leading to respiratory distress syndrome (RDS). By reducing surface tension, surfactants help keep the alveoli open, making it easier for the infant to breathe and for oxygen to enter the bloodstream.
While all surfactants in this class serve the same basic function, their composition varies slightly. Curosurf (Poractant alfa) is derived from porcine (pig) lung extract, Infasurf (Calfactant) from calf lung extract, and Survanta (Beractant) from bovine (cow) lung extract. These differences may affect how quickly the medication works or how it is dosed, but all are effective in treating RDS.
Benefits of Surfactant Therapy
Surfactants are primarily used to treat respiratory distress syndrome (RDS) in premature infants, a condition where the lungs are underdeveloped and lack sufficient natural surfactant. Without treatment, RDS can cause severe breathing difficulties and even be life-threatening. Surfactant therapy is preferred because it directly addresses the root cause of RDS by replacing the missing surfactant in the lungs. This helps the infant breathe more easily and improves oxygen levels in the blood.
Surfactants may also be used in some cases of acute respiratory distress syndrome (ARDS) in adults, though this is less common. If you or a loved one is experiencing respiratory issues, consult a healthcare provider. You can schedule a telemedicine appointment with one of our providers to discuss treatment options.
Potential Side Effects of Surfactant Therapy
Like all medications, surfactants can cause side effects. However, not everyone will experience them, and the severity can vary. Below is a list of potential side effects, starting with the most common. It’s important to discuss any concerns with your healthcare provider, especially if you are at higher risk for certain side effects.
Common Side Effects (Greater than 1%)
Transient bradycardia (slow heart rate) – Occurs in approximately 10-20% of patients. This is usually temporary and resolves on its own but may require monitoring, especially in premature infants.
Oxygen desaturation (low oxygen levels) – Occurs in about 5-10% of patients. This is more common in patients with underlying respiratory conditions and may require supplemental oxygen or ventilation adjustments.
Hypotension (low blood pressure) – Seen in around 1-5% of patients. This side effect is more likely in critically ill patients or those with pre-existing cardiovascular issues. Blood pressure monitoring is essential during treatment.
Less Common Side Effects (Less than 1%)
These side effects are rare but can still occur. If you experience any of these, contact your healthcare provider immediately:
- Airway obstruction
- Infection
- Pulmonary hemorrhage (bleeding in the lungs)
- Apnea (temporary cessation of breathing)
- Severe allergic reactions (anaphylaxis)
Severe Side Effects: Although rare, severe side effects like pulmonary hemorrhage or anaphylaxis require immediate medical attention. If you or your child experiences difficulty breathing, swelling of the face or throat, or severe chest pain, seek emergency care right away.
It’s crucial to consult your healthcare provider before starting surfactant therapy, especially if you or your child has a history of lung disease, heart conditions, or allergies. Our telemedicine providers are available to discuss your concerns and help you make an informed decision.
Drug to Drug Interactions
Surfactants are typically administered in emergency or critical care settings, which makes drug interactions uncommon. However, it is still important to inform your healthcare provider about all medications you or your child are currently taking, including prescription drugs, over-the-counter medications, and supplements. Some potential drug interactions to be aware of include:
- Diuretics: These medications, which help the body eliminate excess fluid, may increase the risk of electrolyte imbalances when used alongside surfactants.
- Bronchodilators: Medications that help open the airways may interact with surfactants, potentially affecting their effectiveness or leading to adverse respiratory effects.
- Antibiotics: Certain antibiotics, particularly aminoglycosides, may heighten the risk of kidney damage when used in combination with surfactants, especially in critically ill patients.
Always inform your healthcare provider about all medications you or your child are taking to help prevent potential interactions. Our telemedicine providers are available to review your medication list and ensure that surfactant therapy is safe for you or your child.
Precautions and Contraindications for Surfactant Therapy
Before starting surfactant therapy, it’s important to consider certain precautions and contraindications. While surfactants, including pulmonary surfactants, are generally safe when used as directed, some situations require extra caution:
- Premature Infants: Surfactants are most commonly used in premature infants with respiratory distress syndrome (RDS). However, these infants are more susceptible to side effects such as bradycardia (slow heart rate) and oxygen desaturation, so close monitoring is critical.
- Pre-existing Lung Conditions: Patients with conditions like pulmonary hemorrhage or severe lung infections may face a higher risk of complications during surfactant therapy.
- Allergies: If you or your child has a known allergy to any component of the surfactant, it’s essential to inform your healthcare provider. Although rare, severe allergic reactions can occur.
- Cardiovascular Conditions: Patients with heart conditions may be at an increased risk for complications such as hypotension (low blood pressure) or bradycardia during surfactant administration.
Be sure to discuss your medical history with your healthcare provider to determine whether surfactant therapy is appropriate for you or your child. If you have any concerns, our telemedicine providers are available to guide you through the decision-making process.
Conclusion
Surfactants are life-saving medications primarily used to treat newborns with respiratory distress syndrome, though they can also be beneficial for other respiratory conditions. While generally safe, surfactants may cause side effects or interact with other medications, particularly in vulnerable populations such as premature infants or patients with pre-existing lung or heart conditions. Careful monitoring for side effects and a thorough discussion of your medical history with your healthcare provider are essential before starting treatment.
If you have any questions or concerns about surfactant therapy, our telemedicine providers are here to assist you. We can review your medical history, discuss potential risks, and ensure that you or your child receives the best possible care. Schedule a telemedicine consultation with one of our providers today to get started.
